Bridging Differences in Outcomes of Pharmacoepidemiological Studies: Design and First Results of the PROTECT Project

May-14

Cardiovascular Database Endocrinology Hepatology Mental Health Musculoskeletal Pharmacoepidemiology

AUTHORS : Prof Olaf H. Klungel, Pharmacoepidemiology and Clinical Pharmacology, University of Utrecht, Universiteitsweg 99, PO Box 80082, 3584CG Utrecht, the Netherlands – Email: O.H.Klungel@uu.nl – Profile: https://www.uu.nl/staff/OHKlungel

JOURNAL : Pharmacoepidemiology and Drug Safety

REFERENCE: 9(2):130-8

DOI : 10.2174/1574884708666131111211802

Bridging Differences in Outcomes of Pharmacoepidemiological Studies: Design and First Results of the PROTECT Project

More publications

Comparative effect of aspirin versus clopidogrel monotherapy on incident type 2 diabetes in patients with atherosclerotic cardiovascular diseases: A target trial emulation study

Postoperative Weight Loss After Antiobesity Medications and Revision Risk After Joint Replacement

Comparative effectiveness and prescribing trends of modified release versus immediate release indapamide in patients with hypertension: cohort study